Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
批准号:
8470151
负责人:
LAUREN M JANSSON
金额:
$47.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2016-05-31
关键词:
AffectAge-MonthsBirthBuprenorphineClinicalClinical ResearchComplexCross-Sectional StudiesDataData CollectionDependencyDevelopmentDigestive Signs and SymptomsDoseExhibitsFetusFunctional disorderGestational AgeGoalsGuidelinesIncidenceInfantInfant autonomic nervous systemKnowledgeMaintenanceMediatingMethadoneMothersNeonatalNeonatal Abstinence SyndromeNervous system structureNeurobiologyNewborn InfantOpiatesOpioidOutcomePatientsPerinatalPharmaceutical PreparationsPhysiologicalPopulationPregnancyPregnant WomenProblem behaviorProviderRecruitment ActivityResearchResearch PersonnelResearch Project GrantsRespiratory SystemSafetyScheduleSecond Pregnancy TrimesterSeveritiesStudy SubjectSymptomsTechniquesThird Pregnancy TrimesterTimeWithdrawalWomanWorkcohortexperiencefetalimprovedin uterointerestneonateneurobehaviorneurobehavioralpregnantresearch facility
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The population of opioid dependent pregnant women and their fetuses and infants are a highly vulnerable and complex group that are currently poorly understood. Infants display a range of physiologic and behavioral problems that are widely variable, have unknown pathophysiology, and are characterized by significant deficits in neuroregulatory functioning. Research by this team has shown that methadone negatively affects fetal neurobehaviors in late gestation, and that severity of newborn neuroregulatory dysfunction is related to maternal and infant autonomic nervous system activity. New research has shown the optimality of buprenorphine maintenance during pregnancy as compared to methadone, principally due to improved neonatal outcomes, which is likely to result in increased numbers of providers and patients seeking this medication for treatment of opioid dependency during pregnancy. However, little information regarding the effects of buprenorphine on the developing fetus and infant exists. Pilot data from this group of investigators has suggested that buprenorphine, as compared to methadone-exposed fetuses, exhibit more optimal fetal functioning in the second and third trimesters of gestation. With this proposed research project, we intend to track the longitudinal neurobehavioral development of the buprenorphine-exposed fetus across gestation through 1 month of age in an effort to determine the safety of this medication for use during gestation, the relationship between maternal physiologic changes due to buprenorphine administration and newborn functioning, and to determine potential fetal neurobehavioral markers that may predict NAS expression and infant neurobehavioral outcome. Comparisons to results from a similar project in methadone-exposed pregnancies will be made. This proposal seeks to advance the way we inform the treatment of the opioid dependent woman during pregnancy and her infant after birth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
-
批准号:10307111
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2017
-
负责人:LAUREN M JANSSON
-
依托单位:
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
-
批准号:9557471
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2017
-
负责人:LAUREN M JANSSON
-
依托单位:
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
-
批准号:10062932
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2017
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
-
批准号:8610598
-
项目类别:
-
资助金额:$9.3万
-
财政年份:2011
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
-
批准号:8660678
-
项目类别:
-
资助金额:$49.94万
-
财政年份:2011
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavioral Effects of Maternal Buprenorphine Treatment
-
批准号:8797975
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2011
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
-
批准号:8153652
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2011
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
-
批准号:8858597
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2011
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment
-
批准号:8308404
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2011
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavior in Opiate Dependent Women
-
批准号:7493105
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2005
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavior in Opiate Dependent Women
-
批准号:7107294
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2005
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavior in Opiate Dependent Women
-
批准号:7283536
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2005
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavior in Opiate Dependent Women
-
批准号:6958167
-
项目类别:
-
资助金额:$40.21万
-
财政年份:2005
-
负责人:LAUREN M JANSSON
-
依托单位:
Fetal and Infant Neurobehavior in Opiate Dependent Women
-
批准号:7686107
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2005
-
负责人:LAUREN M JANSSON
-
依托单位:
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT
-
批准号:6651667
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2000
-
负责人:LAUREN M JANSSON
-
依托单位:
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT
-
批准号:6805282
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2000
-
负责人:LAUREN M JANSSON
-
依托单位:
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT
-
批准号:6653747
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2000
-
负责人:LAUREN M JANSSON
-
依托单位:
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT
-
批准号:6192853
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2000
-
负责人:LAUREN M JANSSON
-
依托单位:
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT
-
批准号:6378336
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2000
-
负责人:LAUREN M JANSSON
-
依托单位:
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT
-
批准号:6523121
-
项目类别:
-
资助金额:$15.76万
-
财政年份:2000
-
负责人:LAUREN M JANSSON
-
依托单位: